Published April 18, 2017 | Version v1
Patent Open

Antibody-light fusion products for cancer therapeutics

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases.

Files

US9623116.pdf

Files (1.1 MB)

Name Size Download all
md5:40d891fb855e06300f7347499938155b
1.1 MB Preview Download

Additional details

Identifiers

Patent application number
US 201514717808 A
Patent number
US 9623116 B2
Other
oai:uchicago.tind.io:8090

Dates

Patent filed
2015-05-20

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pathology